Phase II Study of a 3-Day Schedule with Topotecan and Cisplatin in Patients with Previously Untreated Small Cell Lung Cancer and Extensive Disease-Reference-Cited by-同舟云学术

Phase II Study of a 3-Day Schedule with Topotecan and Cisplatin in Patients with Previously Untreated Small Cell Lung Cancer and Extensive Disease

Published:2008-08 Issue:8 Volume:3 Page:902-906
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Sorensen Morten,Lassen Ulrik,Jensen Peter Buhl,Østerlind Kell,Jeppesen Nina,Jensen Britta Bjerregaard,Mellemgaard Anders,Rytter Carsten,Langer Seppo Wang

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference24 articles.

1. Phase II study of topotecan in patients with extensive-stage small-cell carcinoma of the lung: an Eastern Cooperative Oncology Group Trial;Schiller;J Clin Oncol,1996

2. Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative Group.

3. Topotecan versus cyclophosphamide, doxorubicin, and vincristine for the treatment of recurrent small-cell lung cancer;von Pawel;J Clin Oncol,1999

4. Cytotoxic effects of topotecan combined with various anticancer agents in human cancer cell lines;Kaufmann;J Natl Cancer Inst,1996

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Randomized phase III trial in extended stage small cell lung cancer comparing first line platinum in combination with etoposide or topotecan;Acta Oncologica;2023-11-07

2. A systematic review of survival following anti-cancer treatment for small cell lung cancer;Lung Cancer;2020-03

3. DNA Damage-inducing Compounds: Unraveling their Pleiotropic Effects Using High Throughput Sequencing;Current Medicinal Chemistry;2017-06-30

4. E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer;Cancer Chemotherapy and Pharmacology;2013-11-28

5. ERCC1 and topoisomerase I expression in small cell lung cancer: Prognostic and predictive implications;International Journal of Oncology;2012-02-16